- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01561118
DiaSport - Endurance-orientated Training Program With Children and Adolescents on Maintenance Hemodialysis (DiaSport)
DiaSport - Ausdauerorientiertes Trainingsprogramm Mit Kindern Und Jugendlichen an Der Dialyse (DiaSport - Endurance-orientated Training Program With Children and Adolescents on Maintenance Hemodialysis)
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bonn, Germany, 53113
- University Hospital Bonn. Department of Pediatric and Adolescent Medicine, Division of Pediatric Nephrology
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- End stage renal disease with need of renal replacement therapy
- children and adolescents aged ≥6 to ≤19 years
- maintenance hemodialysis for at least 3 months
- Stable and appropriate dialysis condition in the last 4 weeks before inclusion to the study (basically stable blood and dialysate flow rate and same dialyser)
- single pool Kt/V according to Dialysestandard 2006 > 1.2
- Informed consent
Exclusion Criteria:
- Participation in another interventional clinical trial
- severe primary neurologic, orthopaedic or cardiac disease, or secondary disease known as a contraindication for endurance training
- uncontrolled hyper- or hypotension, or cardiac disease
- Recurrent uncontrolled epileptic seizures
- dialysis shunt at the lower limbs
- pregnancy
- already planned medical intervention, for example living donor kidney transplantation or any other surgery, within the first period of the trial which will cause cancelation of more then 3 training units in a row
- Subjects who are in dependency to the sponsor or the PI of the trial, or confined to an institution on judicial or official behalf
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Bicycle-Ergometer Training Group
Performance adapted, hence individualised three times weekly bicycle-ergometer training during hemodialysis. Each training will last 30 to 50 minutes, with 70-80% of the patient specific maximum workload over 12 weeks (36 training sessions). In the second part of the study intervention will be prolonged for another 12 weeks. |
Performance adapted, hence individualised three times weekly bicycle-ergometer training during hemodialysis. Each training will last 30 to 50 minutes with 70-80% of the patient specific maximum workload over 12 weeks (36 training sessions - first part of the study compared to no intervention). In the second part of the study both groups get the opportunity for another 12 weeks of individualised three times weekly bicycle-ergometer training during hemodialysis. |
|
Other: Control
No intervention during hemodialysis during the first 12 weeks of the study. In the second part of the study a training program, according to that of the intervention group, will be performed with a performance adapted, hence individualised three times weekly bicycle-ergometer training during hemodialysis. Each training will last 30 to 50 minutes, with 70-80% of the patient specific maximum workload over 12 weeks (36 training sessions). |
Performance adapted, hence individualised three times weekly bicycle-ergometer training during hemodialysis. Each training will last 30 to 50 minutes with 70-80% of the patient specific maximum workload over 12 weeks (36 training sessions - first part of the study compared to no intervention). In the second part of the study both groups get the opportunity for another 12 weeks of individualised three times weekly bicycle-ergometer training during hemodialysis. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of single pool Kt/V (KDOQI Guidelines) - expressed as the change of single pool Kt/V from week 0 to 12 of intervention (period 1)
Time Frame: 12 weeks
|
Change of single pool Kt/V (spKt/V) measured at week 12 (V1) compared to baseline (V0).
Single pool Kt/V is the standard measure to assess dialysis efficacy.
As dialysis efficacy is the primary aim of dialysis treatment and the spKt/V is the best way to measure efficacy this figure has an important clinical relevance for the patient.
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of the possible workload (maximum physical performance) achieved
Time Frame: 12 and 24 weeks
|
The maximal possible workload will be determined by an exercise evaluation program with increasing power on a leg bicycle ergometer before a hemodialysis session, measuring the peak oxygen uptake (VO2-peak), heart rate, blood pressure and lactate levels during exercise.
|
12 and 24 weeks
|
|
Quality of Life
Time Frame: 12 and 24 weeks
|
For quality of life assessment the validated and standardized PedsQL® questionnaires will be filled in by patients and parents.
|
12 and 24 weeks
|
|
Change of solute removal during hemodialysis
Time Frame: 12 and 24 weeks
|
Solute removal during hemodialysis has a clear impact on the patient's health and well-being, as it reduces sequelae and offers the patient less restrictions on their diet, which would lead to a better compliance.
|
12 and 24 weeks
|
|
Change of solute removal in the two compartment model (assessed in a subgroup of patients)
Time Frame: 12 and 24 weeks
|
Solute removal in the two compartment model will only be analyzed in patients 12 years of age or older with explicit consent to a second blood drawing 30 minutes after end of hemodialysis session.
It was previously used showing a significant enhancement during exercise, explained by an increase of skeletal muscles perfusion during exercise.
|
12 and 24 weeks
|
|
Inflammation, nutritional status and bone metabolism
Time Frame: 12 and 24 weeks
|
The nutritional status and bone metabolism will be determined as they are important for optimal health and growth of paediatric hemodialysis patients.
Evidence is based on studies that showed trends towards a better nutritional status and less chronic inflammation.
|
12 and 24 weeks
|
|
Body Composition Monitoring (BCM)
Time Frame: 12 and 24 weeks
|
Body Cpomposition Monitoring (BCM) will be performed to exermine further information on nutrional status, overhydration and muscle growth.
|
12 and 24 weeks
|
|
Change of number and dose of medication needed
Time Frame: 12 and 24 weeks
|
Number and dose of medication will be recorded, changes will be evaluated, and data will be correlated to e.g. the measured blood pressure (antihypertensive drugs) or haemoglobin levels (EPO or EPO stimulating agents).
|
12 and 24 weeks
|
|
Telomere length and Telomerase activity
Time Frame: 12 and 24 weeks
|
Telomere length and telomerase activity [units] will be used as markers for cell survival, which may be influenced by endurance training.
|
12 and 24 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Bernd Hoppe, MD, University Hospital of Bonn
- Study Chair: Bettina Schaar, PhD, German Sport University, Cologne
Publications and helpful links
General Publications
- Schaar B, Feldkotter M, Nonn JM, Hoppe B. Cardiorespiratory capacity in children and adolescents on maintenance haemodialysis. Nephrol Dial Transplant. 2011 Nov;26(11):3701-8. doi: 10.1093/ndt/gfr014. Epub 2011 Mar 4.
- Hoppe B, Schaar B. The impact of nutrition and physical activity on long-term survival after pediatric solid organ transplantation. Pediatr Transplant. 2012 Nov;16(7):675-7. doi: 10.1111/j.1399-3046.2012.01663.x. Epub 2012 Feb 21. No abstract available.
- Feldkotter M, Thys S, Adams A, Becker I, Buscher R, Pohl M, Schild R, Pape L, Schmitt CP, Taylan C, Wygoda S, Klaus G, Fehrenbach H, Montoya C, Konrad M, Billing H, Schaar B, Hoppe B. Endurance-oriented training program with children and adolescents on maintenance hemodialysis to enhance dialysis efficacy-DiaSport. Pediatr Nephrol. 2021 Dec;36(12):3923-3932. doi: 10.1007/s00467-021-05114-8. Epub 2021 Jun 12. Erratum In: Pediatr Nephrol. 2021 Sep 9;:
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Uni-Koeln-1137
- DFG HO 1272/21-1 (Other Grant/Funding Number: DFG HO 1272/21-1)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on End Stage Renal Failure on Dialysis
-
Peripal AGUniversity Hospital Birmingham NHS Foundation Trust; Swiss Federal Institute...CompletedRenal Failure | Peritoneal Dialysis | Renal Replacement Therapy | End Stage Renal Failure on Dialysis | End Stage Renal Disease on DialysisUnited Kingdom
-
Sir Mortimer B. Davis - Jewish General HospitalMcGill University Health Centre/Research Institute of the McGill University...Not yet recruitingEnd Stage Renal Disease on Dialysis
-
Chang Gung Memorial HospitalNot yet recruitingEnd Stage Renal Disease on Dialysis | Intradialytic HypotensionTaiwan
-
Tuen Mun HospitalEnrolling by invitationDialysis Efficiency and Transporter Evaluation Computational Tool in Peritoneal Dialysis (DETECT-PD)Peritoneal Dialysis | End-Stage Kidney Disease | End Stage Renal Disease (ESRD) | End Stage Renal Failure on Dialysis | Peritoneal Dialysis Patients | End Stage Renal Disease on Dialysis (Diagnosis)Hong Kong
-
The University of Hong KongBaxter Healthcare CorporationCompleted
-
Massachusetts General HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedEnd Stage Renal Failure on DialysisUnited States
-
Massachusetts General HospitalCompletedEnd Stage Renal Failure on DialysisUnited States
-
Universidade Estadual Paulista Júlio de Mesquita...CompletedEnd Stage Renal Failure on Dialysis
-
Palo Alto Veterans Institute for ResearchUnknownEnd Stage Renal Failure on DialysisUnited States
-
Praxisverbund Dialyse und AphereseCompletedEnd Stage Renal Failure on Dialysis
Clinical Trials on Bicycle-Ergometer Training
-
Hitit UniversityHacettepe UniversityRecruitingHeart Failure With Reduced Ejection FractionTurkey
-
Medical University of ViennaUnknownPrehabilitation
-
Hacettepe UniversityCompletedDuchenne Muscular DystrophyTurkey
-
Oberwaid AGUniversity of Zurich; University of Basel; Institute for Exercise and Health...CompletedDepression | Sleep Disorder | Insomnia | Sleep Initiation and Maintenance Disorders | Sleep | Sleep Disturbance | Sleep Fragmentation | Insomnia Due to Other Mental Disorder | Insomnia, Psychophysiological | Insomnia Related to Another Mental ConditionSwitzerland
-
Rana ElbannaRecruiting
-
Hacettepe UniversityActive, not recruitingCritical Illness | ICU PatientsTurkey (Türkiye)
-
Sahmyook UniversityCompletedStroke | Sarcopenia | Muscle Atrophy | Mobility Limitation | Muscle Quality | Robotic RehabilitationSouth Korea
-
Firat UniversityRecruitingRheumatoid Arthritis (RA | 6 Minutes Stepper TestTurkey
-
Vastra Gotaland RegionGöteborg UniversityCompletedHypermobile Ehlers-Danlos Syndrome | Joint Hypermobility SyndromeSweden
-
Hiroshima UniversityCompleted